Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International Randomised Controlled Trial Of Immune Tolerance Induction

NCT00212472 is registered in ClinicalTrials.gov with New York Presbyterian Hospital as lead sponsor.

NCT NCT00212472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00212472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International Randomised Controlled Trial Of Immune Tolerance Induction
Lead sponsor
New York Presbyterian Hospital
Phase
Not applicable
Overall status
Terminated
Start date
July 31, 2002
Completion date
December 31, 2012
Enrollment
134 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a with inhibitors